Nirmatrelvir treatment shows no link to reduced long-COVID risk, study reveals

Recent study reveals nirmatrelvir treatment during acute COVID-19 does not lower the risk of post-acute COVID-19 symptoms, nor is it associated with symptomatic rebound.

Investigational Drug Could Help Vapers Quit

Adding daily use of the investigational drug cytisinicline to behavioral support doubled abstinence rates in e-cigarette users attempting to quit, a randomized phase II trial

May 9, 2024

White House AI order calls for crackdown on abuses, harms in health care

President Biden’s executive order on artificial intelligence amounts to a giant course correction in health care. The actions taken in response could dramatically reshape how

October 31, 2023

Promising gene therapy could transform heart failure treatment

A new gene therapy can reverse the effects of heart failure and restore heart function in a large animal model.

December 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.